Equity Research, Broker Reports, and media content on ACTIVE BIOTECH AB

  • Access the latest forecasts, broker valuations, multiples, and video content from the city about ACTIVE BIOTECH AB
  • See live updates from analysts, company announcements, and other news in a personalised/single dashboard

Research, Charts & Company Announcements

Research Tree provides access to ongoing research coverage, media content and regulatory news on ACTIVE BIOTECH AB. We currently have 0 research reports from 0 professional analysts.

Open
17.3
Volume
0.2m
Range
17.2/18.0
Market Cap
1,723,472,502m
52 Week
8.00/19.9
Date Source Announcement
27Apr17 07:30 GNW Active Biotech: Interim report January - March 2017
12Apr17 12:30 GNW Active Biotech: FDA grants Orphan Drug Designation for tasquinimod for the treatment of multiple myeloma
16Feb17 07:30 GNW Active Biotech AB Year-end report January - December 2016
09Jan17 12:00 GNW The European Patent Office grants patent for tasquinimod for treatment of multiple myeloma
30Dec16 07:30 GNW Number of shares and votes in Active Biotech
12Dec16 16:31 GNW Active Biotech's rights issue completed
22Nov16 14:05 GNW Active Biotech's election committee appointed
  • Frequency of research reports

     

  • Research reports on

    ACTIVE BIOTECH AB

  • Providers covering

    ACTIVE BIOTECH AB